Health and Human Services Secretary Robert F. Kennedy Jr. has halted nearly half a billion dollars in funding for mRNA-based respiratory vaccines—and thereby ended America’s leadership research into ...

Merck’s MRK strong foothold in the oncology space is propelled by its biggest revenue driver, Keytruda. The blockbuster PD-L1 ...